2. Liu Z, Huang Q, Ding M, Wang T, Chen Y, Zhang K. BRCA2 mutations in familial breast cancer with prostate cancer: a case report and literature review. Front Oncol. 2024 Sep 19;14:1428849. doi: 10.3389/fonc.2024.1...
[3]Oh M, Alkhushaym N, Fallatah S, et al. The association of BRCA1 and BRCA2 mutations with prostate cancer risk, frequency, and mortality: A meta-analysis. Prostate. 2019;79(8):880-895. doi:10.1002/pros.23795 [4]Hu C, Hart SN, Polley EC, et al. Association Between Inherited Ge...
Men diagnosed as having prostate cancer need to be treated quickly and aggressively with surgery or radiotherapy rather than put under active surveillance if they have inherited the BRCA2 mutation, a study has found. The study, published in the Journal of Clinical Oncology on 8 April,1 found ...
[3]Oh M, Alkhushaym N, Fallatah S, et al. The association of BRCA1 and BRCA2 mutations with prostate cancer risk, frequency, and mortality: A meta-analysis. Prostate. 2019;79(8):880-895. doi:10.1002/pros.23795 [4]Hu C, Hart SN, Polley EC, et al. Association Between Inherited Ge...
[3]Oh M, Alkhushaym N, Fallatah S, et al. The association of BRCA1 and BRCA2 mutations with prostate cancer risk, frequency, and mortality: A meta-analysis. Prostate. 2019;79(8):880-895. doi:10.1002/pros.23795 [4]Hu C, Hart SN, Polley EC, et al. Association Between Inherited Ge...
Omura M, Kosaka T, Aimono E, Nakamura K, Hongo H, Mikami S, Nishihara H, Oya M. First successful case of platinum-based chemotherapy for neuroendocrine prostate cancer with BRCA2 and PTEN alterations. IJU Case Rep. 2021 Oct 20;5(1):41-44. doi: 10.1002/iju5.12383. PMID: 35005470; PM...
BRCA1 and BRCA2 pathogenic variants (PVs) are associated with prostate cancer (PCa) risk, but a wide range of relative risks (RRs) has been reported. We systematically searched PubMed, Embase, MEDLINE and Cochrane Library in June 2021 for studies that es
Omura M, Kosaka T, Aimono E, Nakamura K, Hongo H, Mikami S, Nishihara H, Oya M. First successful case of platinum-based chemotherapy for neuroendocrine prostate cancer with BRCA2 and PTEN alterations. IJU Case Rep....
PCa harbour increased genomic instability and a mutational profile that more closely resembles metastastic than localized disease.BRCA2-mutant PCa shows genomic and epigenomic dysregulation of theMED12L/MED12axis, which is frequently dysregulated in metastatic castration-resistant prostate cancer (mCRPC). ...
19、te cancer with brca1 and brca2 founder mutationsj.clinical cancer research,2009,15(3):1112-1120.7 oh m,alkhushaym n,fallatah s,et al.the association of brca1 and brca2 mutations with prostate cancer risk,frequency,and mortality:a meta-nalysisj.the prostate,2019,79(8):880-895.8 try...